HTLV- I infection is not associated with a higher risk of death in peruvian HIV-infected patients
Open Access
- 1 August 2009
- journal article
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 51 (4), 197-201
- https://doi.org/10.1590/s0036-46652009000400004
Abstract
Limited and contradictory information exists regarding the prognosis of HIV/HTLV-I co-infection. Our goal was to estimate the effect of HTLV-I infection on mortality in HIV-infected patients at a HIV reference center in Peru. We studied a retrospective cohort of HIV-infected patients, who were exposed or unexposed to HTLV-I. Exposed patients were Western Blot (WB) positive for both retroviruses. Unexposed patients were WB positive for HIV, and had least one negative EIA for HTLV-I. These were selected among patients who entered our Program immediately before and after each exposed patient, between January 1990 and June 2004. Survival time was considered between the diagnosis of exposure to HTLV-I and death or censoring. Confounding variables were age, gender, baseline HIV clinical stage, baseline CD4+ T cell count, and antiretroviral therapy. We studied 50 exposed, and 100 unexposed patients. Exposed patients had a shorter survival compared to unexposed patients [median survival: 47 months (95% CI: 17-77) vs. 85 months (95% CI: 70-100), unadjusted p = 0.06]. Exposed patients had a higher rate of mortality compared to unexposed patients (HIV/HTLV-I (24/50 [48%]) vs. HIV only (37/100 [37%]), univariable p = 0.2]. HTLV-I exposure was not associated to a higher risk of death in the adjusted analysis: HR: 1.2 (0.4-3.5). AIDS clinical stage and lack of antiretroviral therapy were associated to a higher risk of dying. In conclusions, HTLV-I infection was not associated with a higher risk of death in Peruvian HIV-infected patients. Advanced HIV infection and lack of antiretroviral therapy may explain the excess of mortality in this population.Keywords
This publication has 13 references indexed in Scilit:
- Coinfection with HIV and Human T Lymphotropic Virus Type 1: What Is the Real Impact on HIV Disease?Clinical Infectious Diseases, 2005
- Clinical Outcomes and Disease Progression among Patients Coinfected with HIV and Human T Lymphotropic Virus Types 1 and 2Clinical Infectious Diseases, 2004
- Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV 1) infection among ethnically and geographically diverse Peruvian womenInternational Journal of Infectious Diseases, 2003
- Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, BrazilAIDS, 2001
- Role of HTLV-1 co-infection in the AIDS epidemic in the Caribbean: a cause for concern.International Journal of STD & AIDS, 1999
- Coinfection with Human Immunodeficiency Virus and Human T‐Cell Lymphotropic Virus Type I: Reciprocal Activation with Clinical and Immunologic ConsequencesClinical Infectious Diseases, 1997
- Retroviral Coinfections at a New Orleans HIV Outpatient ClinicJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Immunodeficiency and Elevated CD4 T Lymphocyte Counts in Two Patients Coinfected with Human Immunodeficiency Virus and Human Lymphotropic Virus Type IClinical Infectious Diseases, 1995
- HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug usersThe Lancet, 1990
- PROGRESSION TO AIDS IN HOMOSEXUAL MEN CO-INFECTED WITH HIV AND HTLV-I IN TRINIDADThe Lancet, 1987